Continuing increase in the incidence of serogroup C meningococcal disease. Should we decide to vaccinate? [1];Continúa aumentando la incidencia de enfermedad meningocócica por serogrupo C. ¿Debemos tomar la decisión de vacunar? [1]

Anales Espanoles de Pediatria

Volumn 53, Issue 1, 2000, Pages 75-76

  Soult Rubio, J A ^a   Munoz Saez M ^a   Lopez Castilla J D ^a   Rodriguez Becerra A ^a   Romero Parreno A ^a   Tovaruela Santos, A ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE;

BLOOD GROUP TYPING; HUMAN; INCIDENCE; INFECTION CONTROL; LETTER; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; SPAIN; VACCINATION;

CHILD; HUMANS; INCIDENCE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; SEROTYPING;

EID: 0034446519     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (9)

1. Aumento en la incidencia de enfermedad meningocócica por serogrupo C en la provincia de Sevilla
2. Sistema de Vigilancia Epidemiológica de Andalucía. Enfermedad meningocócica
3. Control of group C meningococcal disease in Australian aboriginal children by mass rifampicin chemoprophylaxis and vaccination
4. Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents
5. Meningococcal disease prevention and control strategies for practice-based physicians
6. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: Emergence of a virulent clone of Neisseria meningitidis
7. Meningococcal disease-New England, 1993-1998
8. Persistence of antibody following immunization of children with groups A and C meningococcal polysaccharide vaccines
9. Kinetics of antibody production to group C meningococcal polysaccharide vaccines administered during the first six years of life: Prospects for rutine immunization of infant and children